Publications by authors named "Christopher S Knauer"

Claim this Profile
D
Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs.
Tom L McTier, Nathan Chubb, Michael P Curtis, Laura Hedges, Gregory A Inskeep, Christopher S Knauer

Vet Parasitol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an in vitro screen for compound bioaccumulation in Haemonchus contortus.
Xin Zhou, Jinxia Nancy Deng, Bernard D Hummel, Debra J Woods, Wendy T Collard, Christopher S Knauer

J Parasitol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of veterinary antiparasitic agents in the 21st century: a view from industry.
Debra J Woods, Christopher S Knauer

Int J Parasitol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors.
Christopher S Knauer, Jeffrey E Campbell, Christopher L Chio, Lawrence W Fitzgerald

Naunyn Schmiedebergs Arch Pharmacol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a rat in vivo [(3)H]M100907 binding assay to determine a translatable measure of 5-HT(2A) receptor occupancy.
Christopher S Knauer, Jeffrey E Campbell, Betsy Galvan, Christopher Bowman, Sarah Osgood

Eur J Pharmacol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists.
Paul Galatsis, Koji Yamagata, John A Wendt, Cleo J Connolly, John W Mickelson, Christopher S Knauer

Bioorg Med Chem Lett· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heteroatom-linked indanylpyrazines are corticotropin releasing factor type-1 receptor antagonists.
Jeffrey W Corbett, Mark R Rauckhorst, Fang Qian, Robert L Hoffman, Christopher S Knauer

Bioorg Med Chem Lett· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR of 2-aryl pyrido[2,3-d]pyrimidines as potent mGlu5 receptor antagonists.
John A Wendt, Susan D Deeter, Susan E Bove, Christopher S Knauer, Rachel M Brooker

Bioorg Med Chem Lett· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists.
Jared B J Milbank, Christopher S Knauer, Corinne E Augelli-Szafran, Annette T Sakkab-Tan, Kristin K Lin

Bioorg Med Chem Lett· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2,3,4,5-tetrahydro- and 2,3,4,5,11,11a-hexahydro-1H-[1,4]diazepino[1,7-a]indoles: new templates for 5-HT(2C) agonists.
Michael D Ennis, Robert L Hoffman, Nabil B Ghazal, Rebecca M Olson, Christopher S Knauer

Bioorg Med Chem Lett· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis